Skip to main content
NACFC 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session
Session includes invitee/speaker with CF. Others with CF encouraged to participate virtually.
Session includes invitee/speaker with CF. Others with CF encouraged to participate virtually.

Discipline Group Session

CLIN

DG15--Emerging Topics in CF Genetics & Genetic Counseling

Friday, September 27, 2024
7:45 AM - 9:45 AM ET
Location: 252 B
Recorded Session
This session will review recent research updates with a focus on targeted therapies in CF across the lifespan. We will discuss off-label modulator use in pregnancy to treat affected fetuses, in vitro modulator responsiveness of CFTR variants with and without a currently approved modulator, and the current landscape of clinical trials for genetic therapies. This session is appropriate for genetic counselors and other clinicians incorporating genomics into CF care.

Learning Objectives:

  • Summarize logistical considerations and medical outcomes of off-label CFTR modulator use during pregnancy in fetuses with CF
  • Review the process of assessing CFTR variant responsiveness and potential impact on clinical care outcomes, with specific focus on newly published data on variants with and without an approved modulator
  • Discuss the current status and pipeline of clinical trials for genetic therapies (mRNA, gene replacement, and gene editing)